Certa Therapeutics


Key points

  • Diabetes-related fibrosis is the leading cause of end-stage kidney disease
  • There are no products to prevent or reverse diabetes-related fibrosis
  • Phase II clinical trials of lead compound, and genetic testing, will start within a year

Find out more